Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study
Treatment outcomes among survivors of cancer diagnosed during adolescence and early young adulthood have not been characterised independently of survivors of cancers diagnosed during childhood. We aimed to describe chronic health conditions and all-cause and cause-specific mortality among survivors...
Saved in:
| Published in: | The lancet oncology Vol. 21; no. 3; pp. 421 - 435 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
Elsevier Ltd
01.03.2020
Elsevier Limited |
| Subjects: | |
| ISSN: | 1470-2045, 1474-5488, 1474-5488 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Treatment outcomes among survivors of cancer diagnosed during adolescence and early young adulthood have not been characterised independently of survivors of cancers diagnosed during childhood. We aimed to describe chronic health conditions and all-cause and cause-specific mortality among survivors of early-adolescent and young adult cancer.
The Childhood Cancer Survivor Study (CCSS) is a retrospective cohort study with longitudinal follow-up of 5-year survivors diagnosed with cancer before the age of 21 years at 27 academic institutions in the USA and Canada between 1970 and 1999. We evaluated outcomes among survivors of early-adolescent and young adult cancer (aged 15–20 years at diagnosis) and survivors diagnosed at age younger than 15 years (matched on primary cancer diagnosis, including leukaemia, lymphoma, CNS tumours, neuroblastoma, Wilms tumour, soft-tissue sarcomas, and bone cancer) by comparing both groups to siblings of the same age. Mortality was ascertained with the National Death Index. Chronic health conditions were classified with the Common Terminology Criteria for Adverse Events. Standardised mortality ratios (SMRs) were estimated with age-specific, sex-specific, and calendar year-specific US rates. Cox proportional hazard models estimated hazard ratios (HRs) for chronic health conditions and 95% CIs.
Among 5804 early-adolescent and young adult survivors (median age 42 years, IQR 34–50) the SMR compared to the general population for all-cause mortality was 5·9 (95% CI 5·5–6·2) and among 5804 childhood cancer survivors (median age 34 years; 27–42), it was 6·2 (5·8–6·6). Early-adolescent and young adult survivors had lower SMRs for death from health-related causes (ie, conditions that exclude recurrence or progression of the primary cancer and external causes, but include the late effects of cancer therapy) than did childhood cancer survivors (SMR 4·8 [95% CI 4·4–5·1] vs 6·8 [6·2–7·4]), which was primarily evident more than 20 years after cancer diagnosis. Early-adolescent and young adult cancer survivors and childhood cancer survivors were both at greater risk of developing severe and disabling, life-threatening, or fatal (grade 3–5) health conditions than siblings of the same age (HR 4·2 [95% CI 3·7–4·8] for early adolescent and young adult cancer survivors and 5·6 [4·9–6·3] for childhood cancer survivors), and at increased risk of developing grade 3–5 cardiac (4·3 [3·5–5·4] and 5·6 [4·5–7·1]), endocrine (3·9 [2·9–5·1] and 6·4 [5·1–8·0]), and musculoskeletal conditions (6·5 [3·9–11·1] and 8·0 [4·6–14·0]) when compared with siblings of the same age, although all these risks were lower for early-adolescent and young adult survivors than for childhood cancer survivors.
Early-adolescent and young adult cancer survivors had higher risks of mortality and severe and life threatening chronic health conditions than the general population. However, early-adolescent and young adult cancer survivors had lower non-recurrent, health-related SMRs and relative risks of developing grade 3–5 chronic health conditions than childhood cancer survivors, by comparison with siblings of the same age, which were most notable more than 20 years after their original cancer. These results highlight the need for long-term screening of both childhood and early-adolescent and young adult cancer survivors.
National Cancer Institute and American Lebanese-Syrian Associated Charities. |
|---|---|
| AbstractList | Treatment outcomes among survivors of cancer diagnosed during adolescence and early young adulthood have not been characterised independently of survivors of cancers diagnosed during childhood. We aimed to describe chronic health conditions and all-cause and cause-specific mortality among survivors of early-adolescent and young adult cancer.BACKGROUNDTreatment outcomes among survivors of cancer diagnosed during adolescence and early young adulthood have not been characterised independently of survivors of cancers diagnosed during childhood. We aimed to describe chronic health conditions and all-cause and cause-specific mortality among survivors of early-adolescent and young adult cancer.The Childhood Cancer Survivor Study (CCSS) is a retrospective cohort study with longitudinal follow-up of 5-year survivors diagnosed with cancer before the age of 21 years at 27 academic institutions in the USA and Canada between 1970 and 1999. We evaluated outcomes among survivors of early-adolescent and young adult cancer (aged 15-20 years at diagnosis) and survivors diagnosed at age younger than 15 years (matched on primary cancer diagnosis, including leukaemia, lymphoma, CNS tumours, neuroblastoma, Wilms tumour, soft-tissue sarcomas, and bone cancer) by comparing both groups to siblings of the same age. Mortality was ascertained with the National Death Index. Chronic health conditions were classified with the Common Terminology Criteria for Adverse Events. Standardised mortality ratios (SMRs) were estimated with age-specific, sex-specific, and calendar year-specific US rates. Cox proportional hazard models estimated hazard ratios (HRs) for chronic health conditions and 95% CIs.METHODSThe Childhood Cancer Survivor Study (CCSS) is a retrospective cohort study with longitudinal follow-up of 5-year survivors diagnosed with cancer before the age of 21 years at 27 academic institutions in the USA and Canada between 1970 and 1999. We evaluated outcomes among survivors of early-adolescent and young adult cancer (aged 15-20 years at diagnosis) and survivors diagnosed at age younger than 15 years (matched on primary cancer diagnosis, including leukaemia, lymphoma, CNS tumours, neuroblastoma, Wilms tumour, soft-tissue sarcomas, and bone cancer) by comparing both groups to siblings of the same age. Mortality was ascertained with the National Death Index. Chronic health conditions were classified with the Common Terminology Criteria for Adverse Events. Standardised mortality ratios (SMRs) were estimated with age-specific, sex-specific, and calendar year-specific US rates. Cox proportional hazard models estimated hazard ratios (HRs) for chronic health conditions and 95% CIs.Among 5804 early-adolescent and young adult survivors (median age 42 years, IQR 34-50) the SMR compared to the general population for all-cause mortality was 5·9 (95% CI 5·5-6·2) and among 5804 childhood cancer survivors (median age 34 years; 27-42), it was 6·2 (5·8-6·6). Early-adolescent and young adult survivors had lower SMRs for death from health-related causes (ie, conditions that exclude recurrence or progression of the primary cancer and external causes, but include the late effects of cancer therapy) than did childhood cancer survivors (SMR 4·8 [95% CI 4·4-5·1] vs 6·8 [6·2-7·4]), which was primarily evident more than 20 years after cancer diagnosis. Early-adolescent and young adult cancer survivors and childhood cancer survivors were both at greater risk of developing severe and disabling, life-threatening, or fatal (grade 3-5) health conditions than siblings of the same age (HR 4·2 [95% CI 3·7-4·8] for early adolescent and young adult cancer survivors and 5·6 [4·9-6·3] for childhood cancer survivors), and at increased risk of developing grade 3-5 cardiac (4·3 [3·5-5·4] and 5·6 [4·5-7·1]), endocrine (3·9 [2·9-5·1] and 6·4 [5·1-8·0]), and musculoskeletal conditions (6·5 [3·9-11·1] and 8·0 [4·6-14·0]) when compared with siblings of the same age, although all these risks were lower for early-adolescent and young adult survivors than for childhood cancer survivors.FINDINGSAmong 5804 early-adolescent and young adult survivors (median age 42 years, IQR 34-50) the SMR compared to the general population for all-cause mortality was 5·9 (95% CI 5·5-6·2) and among 5804 childhood cancer survivors (median age 34 years; 27-42), it was 6·2 (5·8-6·6). Early-adolescent and young adult survivors had lower SMRs for death from health-related causes (ie, conditions that exclude recurrence or progression of the primary cancer and external causes, but include the late effects of cancer therapy) than did childhood cancer survivors (SMR 4·8 [95% CI 4·4-5·1] vs 6·8 [6·2-7·4]), which was primarily evident more than 20 years after cancer diagnosis. Early-adolescent and young adult cancer survivors and childhood cancer survivors were both at greater risk of developing severe and disabling, life-threatening, or fatal (grade 3-5) health conditions than siblings of the same age (HR 4·2 [95% CI 3·7-4·8] for early adolescent and young adult cancer survivors and 5·6 [4·9-6·3] for childhood cancer survivors), and at increased risk of developing grade 3-5 cardiac (4·3 [3·5-5·4] and 5·6 [4·5-7·1]), endocrine (3·9 [2·9-5·1] and 6·4 [5·1-8·0]), and musculoskeletal conditions (6·5 [3·9-11·1] and 8·0 [4·6-14·0]) when compared with siblings of the same age, although all these risks were lower for early-adolescent and young adult survivors than for childhood cancer survivors.Early-adolescent and young adult cancer survivors had higher risks of mortality and severe and life threatening chronic health conditions than the general population. However, early-adolescent and young adult cancer survivors had lower non-recurrent, health-related SMRs and relative risks of developing grade 3-5 chronic health conditions than childhood cancer survivors, by comparison with siblings of the same age, which were most notable more than 20 years after their original cancer. These results highlight the need for long-term screening of both childhood and early-adolescent and young adult cancer survivors.INTERPRETATIONEarly-adolescent and young adult cancer survivors had higher risks of mortality and severe and life threatening chronic health conditions than the general population. However, early-adolescent and young adult cancer survivors had lower non-recurrent, health-related SMRs and relative risks of developing grade 3-5 chronic health conditions than childhood cancer survivors, by comparison with siblings of the same age, which were most notable more than 20 years after their original cancer. These results highlight the need for long-term screening of both childhood and early-adolescent and young adult cancer survivors.National Cancer Institute and American Lebanese-Syrian Associated Charities.FUNDINGNational Cancer Institute and American Lebanese-Syrian Associated Charities. Summary Background Treatment outcomes among survivors of cancer diagnosed during adolescence and early young adulthood have not been characterised independently of survivors of cancers diagnosed during childhood. We aimed to describe chronic health conditions and all-cause and cause-specific mortality among survivors of early-adolescent and young adult cancer. Methods The Childhood Cancer Survivor Study (CCSS) is a retrospective cohort study with longitudinal follow-up of 5-year survivors diagnosed with cancer before the age of 21 years at 27 academic institutions in the USA and Canada between 1970 and 1999. We evaluated outcomes among survivors of early-adolescent and young adult cancer (aged 15–20 years at diagnosis) and survivors diagnosed at age younger than 15 years (matched on primary cancer diagnosis, including leukaemia, lymphoma, CNS tumours, neuroblastoma, Wilms tumour, soft-tissue sarcomas, and bone cancer) by comparing both groups to siblings of the same age. Mortality was ascertained with the National Death Index. Chronic health conditions were classified with the Common Terminology Criteria for Adverse Events. Standardised mortality ratios (SMRs) were estimated with age-specific, sex-specific, and calendar year-specific US rates. Cox proportional hazard models estimated hazard ratios (HRs) for chronic health conditions and 95% CIs. Findings Among 5804 early-adolescent and young adult survivors (median age 42 years, IQR 34–50) the SMR compared to the general population for all-cause mortality was 5·9 (95% CI 5·5–6·2) and among 5804 childhood cancer survivors (median age 34 years; 27–42), it was 6·2 (5·8–6·6). Early-adolescent and young adult survivors had lower SMRs for death from health-related causes (ie, conditions that exclude recurrence or progression of the primary cancer and external causes, but include the late effects of cancer therapy) than did childhood cancer survivors (SMR 4·8 [95% CI 4·4–5·1] vs 6·8 [6·2–7·4]), which was primarily evident more than 20 years after cancer diagnosis. Early-adolescent and young adult cancer survivors and childhood cancer survivors were both at greater risk of developing severe and disabling, life-threatening, or fatal (grade 3–5) health conditions than siblings of the same age (HR 4·2 [95% CI 3·7–4·8] for early adolescent and young adult cancer survivors and 5·6 [4·9–6·3] for childhood cancer survivors), and at increased risk of developing grade 3–5 cardiac (4·3 [3·5–5·4] and 5·6 [4·5–7·1]), endocrine (3·9 [2·9–5·1] and 6·4 [5·1–8·0]), and musculoskeletal conditions (6·5 [3·9–11·1] and 8·0 [4·6–14·0]) when compared with siblings of the same age, although all these risks were lower for early-adolescent and young adult survivors than for childhood cancer survivors. Interpretation Early-adolescent and young adult cancer survivors had higher risks of mortality and severe and life threatening chronic health conditions than the general population. However, early-adolescent and young adult cancer survivors had lower non-recurrent, health-related SMRs and relative risks of developing grade 3–5 chronic health conditions than childhood cancer survivors, by comparison with siblings of the same age, which were most notable more than 20 years after their original cancer. These results highlight the need for long-term screening of both childhood and early-adolescent and young adult cancer survivors. Funding National Cancer Institute and American Lebanese-Syrian Associated Charities. Treatment outcomes among survivors of cancer diagnosed during adolescence and early young adulthood have not been characterised independently of survivors of cancers diagnosed during childhood. We aimed to describe chronic health conditions and all-cause and cause-specific mortality among survivors of early-adolescent and young adult cancer. The Childhood Cancer Survivor Study (CCSS) is a retrospective cohort study with longitudinal follow-up of 5-year survivors diagnosed with cancer before the age of 21 years at 27 academic institutions in the USA and Canada between 1970 and 1999. We evaluated outcomes among survivors of early-adolescent and young adult cancer (aged 15–20 years at diagnosis) and survivors diagnosed at age younger than 15 years (matched on primary cancer diagnosis, including leukaemia, lymphoma, CNS tumours, neuroblastoma, Wilms tumour, soft-tissue sarcomas, and bone cancer) by comparing both groups to siblings of the same age. Mortality was ascertained with the National Death Index. Chronic health conditions were classified with the Common Terminology Criteria for Adverse Events. Standardised mortality ratios (SMRs) were estimated with age-specific, sex-specific, and calendar year-specific US rates. Cox proportional hazard models estimated hazard ratios (HRs) for chronic health conditions and 95% CIs. Among 5804 early-adolescent and young adult survivors (median age 42 years, IQR 34–50) the SMR compared to the general population for all-cause mortality was 5·9 (95% CI 5·5–6·2) and among 5804 childhood cancer survivors (median age 34 years; 27–42), it was 6·2 (5·8–6·6). Early-adolescent and young adult survivors had lower SMRs for death from health-related causes (ie, conditions that exclude recurrence or progression of the primary cancer and external causes, but include the late effects of cancer therapy) than did childhood cancer survivors (SMR 4·8 [95% CI 4·4–5·1] vs 6·8 [6·2–7·4]), which was primarily evident more than 20 years after cancer diagnosis. Early-adolescent and young adult cancer survivors and childhood cancer survivors were both at greater risk of developing severe and disabling, life-threatening, or fatal (grade 3–5) health conditions than siblings of the same age (HR 4·2 [95% CI 3·7–4·8] for early adolescent and young adult cancer survivors and 5·6 [4·9–6·3] for childhood cancer survivors), and at increased risk of developing grade 3–5 cardiac (4·3 [3·5–5·4] and 5·6 [4·5–7·1]), endocrine (3·9 [2·9–5·1] and 6·4 [5·1–8·0]), and musculoskeletal conditions (6·5 [3·9–11·1] and 8·0 [4·6–14·0]) when compared with siblings of the same age, although all these risks were lower for early-adolescent and young adult survivors than for childhood cancer survivors. Early-adolescent and young adult cancer survivors had higher risks of mortality and severe and life threatening chronic health conditions than the general population. However, early-adolescent and young adult cancer survivors had lower non-recurrent, health-related SMRs and relative risks of developing grade 3–5 chronic health conditions than childhood cancer survivors, by comparison with siblings of the same age, which were most notable more than 20 years after their original cancer. These results highlight the need for long-term screening of both childhood and early-adolescent and young adult cancer survivors. National Cancer Institute and American Lebanese-Syrian Associated Charities. SummaryBackgroundTreatment outcomes among survivors of cancer diagnosed during adolescence and early young adulthood have not been characterised independently of survivors of cancers diagnosed during childhood. We aimed to describe chronic health conditions and all-cause and cause-specific mortality among survivors of early-adolescent and young adult cancer. MethodsThe Childhood Cancer Survivor Study (CCSS) is a retrospective cohort study with longitudinal follow-up of 5-year survivors diagnosed with cancer before the age of 21 years at 27 academic institutions in the USA and Canada between 1970 and 1999. We evaluated outcomes among survivors of early-adolescent and young adult cancer (aged 15–20 years at diagnosis) and survivors diagnosed at age younger than 15 years (matched on primary cancer diagnosis, including leukaemia, lymphoma, CNS tumours, neuroblastoma, Wilms tumour, soft-tissue sarcomas, and bone cancer) by comparing both groups to siblings of the same age. Mortality was ascertained with the National Death Index. Chronic health conditions were classified with the Common Terminology Criteria for Adverse Events. Standardised mortality ratios (SMRs) were estimated with age-specific, sex-specific, and calendar year-specific US rates. Cox proportional hazard models estimated hazard ratios (HRs) for chronic health conditions and 95% CIs. FindingsAmong 5804 early-adolescent and young adult survivors (median age 42 years, IQR 34–50) the SMR compared to the general population for all-cause mortality was 5·9 (95% CI 5·5–6·2) and among 5804 childhood cancer survivors (median age 34 years; 27–42), it was 6·2 (5·8–6·6). Early-adolescent and young adult survivors had lower SMRs for death from health-related causes (ie, conditions that exclude recurrence or progression of the primary cancer and external causes, but include the late effects of cancer therapy) than did childhood cancer survivors (SMR 4·8 [95% CI 4·4–5·1] vs 6·8 [6·2–7·4]), which was primarily evident more than 20 years after cancer diagnosis. Early-adolescent and young adult cancer survivors and childhood cancer survivors were both at greater risk of developing severe and disabling, life-threatening, or fatal (grade 3–5) health conditions than siblings of the same age (HR 4·2 [95% CI 3·7–4·8] for early adolescent and young adult cancer survivors and 5·6 [4·9–6·3] for childhood cancer survivors), and at increased risk of developing grade 3–5 cardiac (4·3 [3·5–5·4] and 5·6 [4·5–7·1]), endocrine (3·9 [2·9–5·1] and 6·4 [5·1–8·0]), and musculoskeletal conditions (6·5 [3·9–11·1] and 8·0 [4·6–14·0]) when compared with siblings of the same age, although all these risks were lower for early-adolescent and young adult survivors than for childhood cancer survivors. InterpretationEarly-adolescent and young adult cancer survivors had higher risks of mortality and severe and life threatening chronic health conditions than the general population. However, early-adolescent and young adult cancer survivors had lower non-recurrent, health-related SMRs and relative risks of developing grade 3–5 chronic health conditions than childhood cancer survivors, by comparison with siblings of the same age, which were most notable more than 20 years after their original cancer. These results highlight the need for long-term screening of both childhood and early-adolescent and young adult cancer survivors. FundingNational Cancer Institute and American Lebanese-Syrian Associated Charities. |
| Author | Suh, Eugene Freyer, David R Neglia, Joseph P Stock, Wendy Leisenring, Wendy M McNeer, Jennifer L Krull, Kevin R Oeffinger, Kevin C Henderson, Tara O Sklar, Charles A Stovall, Marilyn Nathan, Paul C Stratton, Kayla L Ford, Jennifer S Robison, Leslie L Armstrong, Gregory T |
| Author_xml | – sequence: 1 givenname: Eugene surname: Suh fullname: Suh, Eugene organization: Loyola University Chicago Health Sciences, Maywood, IL, USA – sequence: 2 givenname: Kayla L surname: Stratton fullname: Stratton, Kayla L organization: Fred Hutchinson Cancer Research Center, Seattle, WA, USA – sequence: 3 givenname: Wendy M surname: Leisenring fullname: Leisenring, Wendy M organization: Fred Hutchinson Cancer Research Center, Seattle, WA, USA – sequence: 4 givenname: Paul C surname: Nathan fullname: Nathan, Paul C organization: The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada – sequence: 5 givenname: Jennifer S surname: Ford fullname: Ford, Jennifer S organization: Hunter College and The Graduate Center, City University of New York, New York, NY, USA – sequence: 6 givenname: David R surname: Freyer fullname: Freyer, David R organization: Children's Hospital Los Angeles, Los Angeles, CA, USA – sequence: 7 givenname: Jennifer L surname: McNeer fullname: McNeer, Jennifer L organization: Department of Pediatrics, University of Chicago, Chicago, IL, USA – sequence: 8 givenname: Wendy surname: Stock fullname: Stock, Wendy organization: Department of Medicine, University of Chicago, Chicago, IL, USA – sequence: 9 givenname: Marilyn surname: Stovall fullname: Stovall, Marilyn organization: The University of Texas MD Anderson Cancer Center, Houston, TX, USA – sequence: 10 givenname: Kevin R surname: Krull fullname: Krull, Kevin R organization: St Jude Children's Research Hospital, Memphis, TN, USA – sequence: 11 givenname: Charles A surname: Sklar fullname: Sklar, Charles A organization: Memorial Sloan Kettering Cancer Center, New York, NY, USA – sequence: 12 givenname: Joseph P surname: Neglia fullname: Neglia, Joseph P organization: University of Minnesota, Minneapolis, MN, USA – sequence: 13 givenname: Gregory T surname: Armstrong fullname: Armstrong, Gregory T organization: St Jude Children's Research Hospital, Memphis, TN, USA – sequence: 14 givenname: Kevin C surname: Oeffinger fullname: Oeffinger, Kevin C organization: Duke University School of Medicine, Durham, NC, USA – sequence: 15 givenname: Leslie L surname: Robison fullname: Robison, Leslie L organization: St Jude Children's Research Hospital, Memphis, TN, USA – sequence: 16 givenname: Tara O surname: Henderson fullname: Henderson, Tara O email: thenderson@peds.bsd.uchicago.edu organization: Department of Pediatrics, University of Chicago, Chicago, IL, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32066543$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkt2K1DAYhousuD96CUrAk_WgmrRNOlVUZPAPBjwYPQ5p8nWbNU3GJB3opXl3pp1xDwZkPWooz_sk-d5cZmfWWciypwS_JJiwV1tS1TgvcEWvSfOixCuM8-ZBdpF-VzmtVquzZX1AzrPLEG4xJjXB9FF2XhaYMVqVF9nvjYiABuejMDpOSFiFZO-d1RL1IEzskXRW6aidDUhbZJy9ySP4AYXR7_Xe-YBch0B4M-VCOQNBgo2LaHKjvUFCjSYiKawEH14jgTxE78IOZNR7SPo-7Z54YaagA-q8G1DsAa17bVTvnELrJYu2xw3RNo5qepw97IQJ8OT4vcp-fPr4ff0l33z7_HX9YZNLRmjMm1K2gjVd09BSEtyqui2pVIy0rMZUSCFUTSumsKpZhRkllJaiZdBRVhdd15ZX2fXBu_Pu1wgh8kGnKxojLLgx8KKkdcVwUxcJfX6C3rrRp4slqiooqxKzStSzIzW2Ayi-83oQfuJ_S0kAPQAyjSl46O4QgvlcPl_K53OznDR8KZ83KffmJCd1FHNz0Qtt7k2_P6QhDXOvwfMgNaTBK-1TVVw5fa_h3YlBGp0ekjA_YYJwNwvCQ8HxQTI7SLMYZsHbfwv-4wB_AFot8_Q |
| CitedBy_id | crossref_primary_10_1007_s12012_025_09981_7 crossref_primary_10_1016_j_beha_2022_101403 crossref_primary_10_3390_cancers13194870 crossref_primary_10_3390_cancers16020272 crossref_primary_10_1089_jayao_2023_0111 crossref_primary_10_1016_j_clindermatol_2025_01_013 crossref_primary_10_1038_s41467_024_49944_0 crossref_primary_10_1038_s41467_025_63979_x crossref_primary_10_1210_clinem_dgaf078 crossref_primary_10_1001_jamanetworkopen_2022_20696 crossref_primary_10_1016_j_ejcped_2023_100003 crossref_primary_10_1093_jnci_djae250 crossref_primary_10_3390_cancers13205064 crossref_primary_10_1249_MSS_0000000000003758 crossref_primary_10_1016_j_ijcard_2022_06_063 crossref_primary_10_1080_0284186X_2023_2260946 crossref_primary_10_1186_s40814_022_01128_7 crossref_primary_10_1242_dmm_050704 crossref_primary_10_1089_jayao_2021_0227 crossref_primary_10_1007_s00383_024_05815_9 crossref_primary_10_1186_s40164_025_00660_5 crossref_primary_10_1016_j_ejcped_2024_100199 crossref_primary_10_1177_13591045241301644 crossref_primary_10_1002_ijgo_70139 crossref_primary_10_1016_j_canep_2023_102469 crossref_primary_10_1007_s00246_023_03192_z crossref_primary_10_17650_2782_3202_2024_4_3_99_103 crossref_primary_10_1093_nop_npae037 crossref_primary_10_1097_NCC_0000000000000906 crossref_primary_10_1158_2159_8290_CD_23_0090 crossref_primary_10_1007_s10389_021_01621_y crossref_primary_10_1089_jayao_2023_0130 crossref_primary_10_3390_cancers16112152 crossref_primary_10_1016_j_ecl_2025_03_015 crossref_primary_10_1016_S0140_6736_22_00460_3 crossref_primary_10_1093_jnci_djac091 crossref_primary_10_1093_jncics_pkab046 crossref_primary_10_1016_j_ejca_2020_10_010 crossref_primary_10_1016_j_ejmp_2022_05_003 crossref_primary_10_1002_ijc_35082 crossref_primary_10_1055_a_2381_7299 crossref_primary_10_15446_av_enferm_v40n2_90007 crossref_primary_10_1038_s41591_021_01625_x crossref_primary_10_1007_s10389_020_01361_5 crossref_primary_10_1007_s11764_025_01858_6 crossref_primary_10_1007_s11764_025_01836_y crossref_primary_10_1002_pmrj_13395 crossref_primary_10_3390_antiox11061054 crossref_primary_10_1080_14787210_2023_2171987 crossref_primary_10_7554_eLife_90993_3 crossref_primary_10_1016_j_ejcped_2023_100112 crossref_primary_10_1002_ncp_10921 crossref_primary_10_1002_cpt_3685 crossref_primary_10_1007_s11764_024_01596_1 crossref_primary_10_1038_s41416_022_02038_4 crossref_primary_10_2174_1381612829666230721122011 crossref_primary_10_1016_j_jadohealth_2024_07_020 crossref_primary_10_1093_her_cyaf014 crossref_primary_10_1186_s13063_024_08377_2 crossref_primary_10_1242_dmm_048930 crossref_primary_10_1161_CIR_0000000000001158 crossref_primary_10_1016_j_ejcped_2024_100165 crossref_primary_10_1002_cncr_33823 crossref_primary_10_1002_pbc_28441 crossref_primary_10_1007_s40124_025_00348_8 crossref_primary_10_3390_cancers17071196 crossref_primary_10_1111_jsap_13667 crossref_primary_10_1186_s12885_024_12430_3 crossref_primary_10_1002_med_22059 crossref_primary_10_1002_cam4_5908 crossref_primary_10_1002_pon_6084 crossref_primary_10_1002_ijc_34469 crossref_primary_10_1016_j_anpedi_2024_03_004 crossref_primary_10_1001_jamanetworkopen_2025_8199 crossref_primary_10_1200_OP_24_01075 crossref_primary_10_1093_ije_dyab193 crossref_primary_10_1016_S1470_2045_23_00154_7 crossref_primary_10_1177_11786329241299317 crossref_primary_10_1016_j_jclinepi_2024_111458 crossref_primary_10_1136_bmjopen_2021_059050 crossref_primary_10_1016_j_anpede_2024_04_013 crossref_primary_10_1016_S2468_2667_24_00268_8 crossref_primary_10_1002_pbc_31700 crossref_primary_10_3390_cancers14030710 crossref_primary_10_1016_S2352_4642_22_00344_3 crossref_primary_10_3390_nu15071731 crossref_primary_10_1016_j_colsurfb_2023_113384 crossref_primary_10_1016_j_ejcped_2025_100222 crossref_primary_10_1089_thy_2022_0407 crossref_primary_10_1016_j_ejca_2021_06_004 crossref_primary_10_3390_jcm10081567 crossref_primary_10_1002_cam4_6336 crossref_primary_10_3389_fimmu_2025_1554311 crossref_primary_10_1007_s00520_021_06584_0 crossref_primary_10_1111_ajco_13914 crossref_primary_10_1016_j_ccl_2024_08_001 crossref_primary_10_3389_fcvm_2023_1223660 crossref_primary_10_1002_ijc_33154 crossref_primary_10_1016_j_bulcan_2022_11_009 crossref_primary_10_1016_j_ctrv_2025_102992 crossref_primary_10_1016_j_ijrobp_2023_11_028 crossref_primary_10_1016_j_jpedsurg_2023_07_001 crossref_primary_10_3389_fpsyt_2021_784615 crossref_primary_10_1542_peds_2021_054796 crossref_primary_10_1038_s41598_024_84156_y crossref_primary_10_1007_s13346_023_01466_w crossref_primary_10_1016_S2352_3026_21_00136_8 crossref_primary_10_2196_65001 crossref_primary_10_3390_jcm10204728 crossref_primary_10_1002_cbf_70097 crossref_primary_10_1158_1055_9965_EPI_25_0023 crossref_primary_10_1016_j_jaccao_2023_05_002 crossref_primary_10_1089_jayao_2021_0171 crossref_primary_10_1136_bmjonc_2023_000090 crossref_primary_10_1089_jayao_2021_0179 crossref_primary_10_1001_jamanetworkopen_2024_54010 crossref_primary_10_1186_s12885_022_09295_9 crossref_primary_10_1016_j_bone_2020_115605 crossref_primary_10_1542_peds_2023_061778 crossref_primary_10_1016_j_prp_2024_155523 crossref_primary_10_1093_jncics_pkac077 crossref_primary_10_1186_s12885_025_14235_4 crossref_primary_10_3390_children12080980 crossref_primary_10_1007_s00520_021_06418_z crossref_primary_10_1007_s11764_025_01854_w crossref_primary_10_3390_cancers15071946 crossref_primary_10_1007_s12529_021_10050_w crossref_primary_10_1016_j_pec_2020_11_009 crossref_primary_10_1038_s41591_023_02339_y crossref_primary_10_1007_s11764_024_01741_w crossref_primary_10_1016_j_ejon_2024_102612 crossref_primary_10_7554_eLife_90993 crossref_primary_10_1177_10732748241270564 crossref_primary_10_7717_peerj_16025 crossref_primary_10_1002_pbc_30141 crossref_primary_10_1111_cch_13207 crossref_primary_10_1002_pon_5647 crossref_primary_10_1016_j_lanepe_2025_101363 crossref_primary_10_1002_pbc_28740 crossref_primary_10_1007_s11764_023_01433_x crossref_primary_10_1186_s12906_023_03896_y crossref_primary_10_3389_fped_2021_721926 crossref_primary_10_1007_s00761_023_01348_3 crossref_primary_10_1177_27536130241238150 crossref_primary_10_3390_cancers15020420 crossref_primary_10_1007_s00520_023_07623_8 crossref_primary_10_1002_cam4_70225 crossref_primary_10_1371_journal_pone_0298068 crossref_primary_10_1111_ipd_13199 crossref_primary_10_1038_s41390_025_03847_y crossref_primary_10_1016_j_ejca_2025_115443 crossref_primary_10_1089_jayao_2023_0150 crossref_primary_10_1007_s11764_024_01610_6 crossref_primary_10_1007_s11864_023_01100_4 crossref_primary_10_1016_j_ejca_2021_10_035 crossref_primary_10_1016_j_ejon_2023_102377 crossref_primary_10_3390_cancers13122942 crossref_primary_10_3390_children9060824 crossref_primary_10_1089_jayao_2023_0159 crossref_primary_10_1200_JCO_24_01678 crossref_primary_10_3389_fonc_2022_982110 crossref_primary_10_1186_s12982_025_00626_2 crossref_primary_10_1097_SLA_0000000000004579 crossref_primary_10_1007_s10238_024_01368_2 crossref_primary_10_3389_fonc_2025_1598921 crossref_primary_10_1016_j_soncn_2023_151434 crossref_primary_10_1016_j_hfc_2022_02_014 crossref_primary_10_1007_s11764_025_01832_2 crossref_primary_10_1002_cam4_70929 crossref_primary_10_3390_medicina59071209 crossref_primary_10_1007_s12672_023_00810_3 crossref_primary_10_1016_j_radonc_2023_109963 crossref_primary_10_1093_jnci_djae284 crossref_primary_10_1007_s11764_022_01296_8 crossref_primary_10_1007_s10815_020_01794_7 crossref_primary_10_1007_s12032_023_02115_5 crossref_primary_10_1089_jayao_2024_0143 crossref_primary_10_1136_fmch_2025_003362 crossref_primary_10_1016_j_leukres_2023_107032 crossref_primary_10_1007_s00520_021_06538_6 crossref_primary_10_1001_jamanetworkopen_2024_10731 crossref_primary_10_1158_1055_9965_EPI_25_0360 crossref_primary_10_1016_j_jconrel_2022_06_010 crossref_primary_10_3390_children9091340 crossref_primary_10_1093_jncics_pkac059 crossref_primary_10_1016_j_ejcped_2023_100025 crossref_primary_10_3390_children10061073 crossref_primary_10_1016_S1470_2045_19_30858_7 crossref_primary_10_1080_09553002_2023_2173823 crossref_primary_10_1007_s00432_023_04756_5 crossref_primary_10_3322_caac_21637 crossref_primary_10_3390_cancers15041094 crossref_primary_10_3389_fcvm_2021_763557 crossref_primary_10_1038_s43018_024_00745_w crossref_primary_10_1097_OR9_0000000000000118 crossref_primary_10_1002_pbc_30564 crossref_primary_10_1038_s41568_024_00775_7 crossref_primary_10_1038_s41572_021_00308_8 crossref_primary_10_1001_jamanetworkopen_2023_23115 crossref_primary_10_1002_pbc_30565 crossref_primary_10_1016_j_omto_2023_08_006 crossref_primary_10_1016_j_pcad_2024_07_002 crossref_primary_10_1371_journal_pone_0314118 crossref_primary_10_1093_intqhc_mzae079 crossref_primary_10_3390_cancers16091661 |
| Cites_doi | 10.7326/M13-1941 10.1182/blood-2008-01-130237 10.1111/j.1541-0420.2010.01420.x 10.1200/JCO.2013.51.1055 10.1056/NEJMsa060185 10.1158/1055-9965.EPI-16-0722 10.1002/pbc.24679 10.1667/RR3525.1 10.1214/aos/1176345976 10.1001/jamaoncol.2015.4393 10.5539/gjhs.v7n2p210 10.1136/bmj.b4606 10.1200/JCO.2009.22.3339 10.1200/JCO.2007.14.9088 10.1200/JCO.2003.06.131 10.1080/01621459.1989.10478874 10.1210/jc.2006-0020 10.1200/JCO.2008.16.9607 10.1002/cncr.30979 10.1056/NEJMoa1510795 10.2174/1573400510666141114223827 10.1089/jayao.2010.0005 10.1200/JCO.2015.61.5187 10.1001/archinternmed.2009.209 |
| ContentType | Journal Article |
| Copyright | 2020 Elsevier Ltd Elsevier Ltd Copyright © 2020 Elsevier Ltd. All rights reserved. 2020. Elsevier Ltd |
| Copyright_xml | – notice: 2020 Elsevier Ltd – notice: Elsevier Ltd – notice: Copyright © 2020 Elsevier Ltd. All rights reserved. – notice: 2020. Elsevier Ltd |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7TO 7X7 7XB 88E 8AO 8C1 8C2 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH H94 K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
| DOI | 10.1016/S1470-2045(19)30800-9 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Lancet Titles Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) Lancet Titles ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Oncogenes and Growth Factors Abstracts MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7RV name: ProQuest Nursing & Allied Health Database url: https://search.proquest.com/nahs sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1474-5488 |
| EndPage | 435 |
| ExternalDocumentID | 32066543 10_1016_S1470_2045_19_30800_9 S1470204519308009 1_s2_0_S1470204519308009 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | United States--US |
| GeographicLocations_xml | – name: United States--US |
| GrantInformation | National Cancer Institute and American Lebanese-Syrian Associated Charities. |
| GrantInformation_xml | – fundername: NCI NIH HHS grantid: P30 CA008748 – fundername: NCI NIH HHS grantid: U24 CA055727 |
| GroupedDBID | --- --K --M -RU .1- .55 .FO 0R~ 123 1B1 1P~ 1~5 29L 4.4 457 4CK 4G. 53G 5VS 6PF 7-5 71M 7RV 7X7 88E 8AO 8C1 8C2 8FI 8FJ AAEDT AAEDW AAIKJ AAKOC AALRI AAMRU AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABMAC ABMZM ABUWG ABWVN ACGFS ACIEU ACLOT ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADMUD ADNMO AEIPS AEKER AENEX AEUPX AEVXI AFKRA AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AHMBA AIGII AIIUN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BENPR BKEYQ BKOJK BNPGV BPHCQ BVXVI CCPQU CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-Q GBLVA HMCUK HVGLF HZ~ IHE J1W KOM M1P M41 MO0 N9A NAPCQ O-L O9- OC~ OO- OZT P-8 P-9 P2P PCD PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO R2- ROL RPZ SDG SEL SES SPCBC SSH SSZ T5K TLN UKHRP UV1 WOW X7M XBR Z5R ~HD 3V. AACTN AFCTW AFKWA AJOXV ALIPV AMFUW RIG SDF ABLVK ABYKQ AHPSJ AJBFU ZA5 9DU AAYXX AFFHD CITATION CGR CUY CVF ECM EIF NPM 7TO 7XB 8FK H94 K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO |
| ID | FETCH-LOGICAL-c615t-93cba69f9953c10bd7b35cd61b6705acaad7546d0d7640651553ab6ef5672ffb3 |
| IEDL.DBID | 8C1 |
| ISICitedReferencesCount | 258 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000518470100046&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1470-2045 1474-5488 |
| IngestDate | Thu Oct 02 05:49:39 EDT 2025 Tue Oct 07 05:14:08 EDT 2025 Thu Apr 03 07:02:12 EDT 2025 Tue Nov 18 20:40:41 EST 2025 Sat Nov 29 06:59:15 EST 2025 Fri Feb 23 02:48:00 EST 2024 Tue Feb 25 20:02:54 EST 2025 Tue Oct 14 19:35:43 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| License | Copyright © 2020 Elsevier Ltd. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c615t-93cba69f9953c10bd7b35cd61b6705acaad7546d0d7640651553ab6ef5672ffb3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/7392388 |
| PMID | 32066543 |
| PQID | 2425647238 |
| PQPubID | 46089 |
| PageCount | 15 |
| ParticipantIDs | proquest_miscellaneous_2357460972 proquest_journals_2425647238 pubmed_primary_32066543 crossref_primary_10_1016_S1470_2045_19_30800_9 crossref_citationtrail_10_1016_S1470_2045_19_30800_9 elsevier_sciencedirect_doi_10_1016_S1470_2045_19_30800_9 elsevier_clinicalkeyesjournals_1_s2_0_S1470204519308009 elsevier_clinicalkey_doi_10_1016_S1470_2045_19_30800_9 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-03-01 |
| PublicationDateYYYYMMDD | 2020-03-01 |
| PublicationDate_xml | – month: 03 year: 2020 text: 2020-03-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | The lancet oncology |
| PublicationTitleAlternate | Lancet Oncol |
| PublicationYear | 2020 |
| Publisher | Elsevier Ltd Elsevier Limited |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited |
| References | (bib14) 2003 Geskus (bib13) 2011; 67 Chemaitilly, Mertens, Mitby (bib23) 2006; 91 Suh, Daugherty, Wroblewski (bib29) 2014; 160 Stovall, Weathers, Kasper (bib11) 2006; 166 Armstrong, Kawashima, Leisenring (bib12) 2014; 32 Sklar, Whitton, Mertens (bib24) 2000; 85 Mulrooney, Yeazel, Kawashima (bib17) 2009; 339 bib30 Green, Nolan, Goodman (bib9) 2014; 61 Bleyer (bib2) 2011; 1 Stock, La, Sanford (bib20) 2008; 112 (bib3) 2006 Oeffinger, Mertens, Sklar (bib4) 2006; 355 Armstrong, Chen, Yasui (bib5) 2016; 374 Kadan-Lottick, Dinu, Wasilewski-Masker (bib25) 2008; 26 Grover, Joshi (bib31) 2014; 7 Oeffinger, Mertens, Sklar (bib21) 2003; 21 Robison, Armstrong, Boice (bib8) 2009; 27 Wolfson, Sun, Wyatt, Stock, Bhatia (bib27) 2017; 26 Fidler, Reulen, Winter (bib6) 2016; 354 Gawade, Hudson, Kaste (bib26) 2014; 10 Howlader, Noone, Krapcho (bib1) April, 2015 Rugbjerg, Olsen (bib7) 2016; 2 Lin, Wei (bib16) 1989; 84 Feijen, Leisenring, Stratton (bib10) 2015; 33 Meacham, Sklar, Li (bib22) 2009; 169 Henderson, Parsons, Wroblewski (bib18) 2018; 124 Andersen, Gill (bib15) 1982; 10 Nathan, Greenberg, Ness (bib28) 2008; 26 Bleyer (bib19) 2007; 57 Grover (10.1016/S1470-2045(19)30800-9_bib31) 2014; 7 Armstrong (10.1016/S1470-2045(19)30800-9_bib5) 2016; 374 Lin (10.1016/S1470-2045(19)30800-9_bib16) 1989; 84 Bleyer (10.1016/S1470-2045(19)30800-9_bib19) 2007; 57 Andersen (10.1016/S1470-2045(19)30800-9_bib15) 1982; 10 Sklar (10.1016/S1470-2045(19)30800-9_bib24) 2000; 85 Rugbjerg (10.1016/S1470-2045(19)30800-9_bib7) 2016; 2 Suh (10.1016/S1470-2045(19)30800-9_bib29) 2014; 160 Kadan-Lottick (10.1016/S1470-2045(19)30800-9_bib25) 2008; 26 Fidler (10.1016/S1470-2045(19)30800-9_bib6) 2016; 354 Stock (10.1016/S1470-2045(19)30800-9_bib20) 2008; 112 Feijen (10.1016/S1470-2045(19)30800-9_bib10) 2015; 33 Mulrooney (10.1016/S1470-2045(19)30800-9_bib17) 2009; 339 Bleyer (10.1016/S1470-2045(19)30800-9_bib2) 2011; 1 Armstrong (10.1016/S1470-2045(19)30800-9_bib12) 2014; 32 Henderson (10.1016/S1470-2045(19)30800-9_bib18) 2018; 124 Howlader (10.1016/S1470-2045(19)30800-9_bib1) 2015 Oeffinger (10.1016/S1470-2045(19)30800-9_bib21) 2003; 21 Wolfson (10.1016/S1470-2045(19)30800-9_bib27) 2017; 26 Chemaitilly (10.1016/S1470-2045(19)30800-9_bib23) 2006; 91 Nathan (10.1016/S1470-2045(19)30800-9_bib28) 2008; 26 Oeffinger (10.1016/S1470-2045(19)30800-9_bib4) 2006; 355 Green (10.1016/S1470-2045(19)30800-9_bib9) 2014; 61 (10.1016/S1470-2045(19)30800-9_bib3) 2006 Geskus (10.1016/S1470-2045(19)30800-9_bib13) 2011; 67 Robison (10.1016/S1470-2045(19)30800-9_bib8) 2009; 27 Gawade (10.1016/S1470-2045(19)30800-9_bib26) 2014; 10 Meacham (10.1016/S1470-2045(19)30800-9_bib22) 2009; 169 Stovall (10.1016/S1470-2045(19)30800-9_bib11) 2006; 166 32066544 - Lancet Oncol. 2020 Mar;21(3):327-329 |
| References_xml | – volume: 67 start-page: 39 year: 2011 end-page: 49 ident: bib13 article-title: Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring publication-title: Biometrics – volume: 112 start-page: 1646 year: 2008 end-page: 1654 ident: bib20 article-title: What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies publication-title: Blood – volume: 10 start-page: 249 year: 2014 end-page: 262 ident: bib26 article-title: A systematic review of selected musculoskeletal late effects in survivors of childhood cancer publication-title: Curr Pediatr Rev – volume: 355 start-page: 1572 year: 2006 end-page: 1582 ident: bib4 article-title: Chronic health conditions in adult survivors of childhood cancer publication-title: N Engl J Med – volume: 7 start-page: 210 year: 2014 end-page: 227 ident: bib31 article-title: An overview of chronic disease models: a systematic literature review publication-title: Glob J Health Sci – volume: 169 start-page: 1381 year: 2009 end-page: 1388 ident: bib22 article-title: Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study publication-title: Arch Intern Med – ident: bib30 article-title: Defining the PMCH – volume: 339 year: 2009 ident: bib17 article-title: Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort publication-title: BMJ – volume: 91 start-page: 1723 year: 2006 end-page: 1728 ident: bib23 article-title: Acute ovarian failure in the childhood cancer survivor study publication-title: J Clin Endocrinol Metab – volume: 354 year: 2016 ident: bib6 article-title: Long term cause specific mortality among 34 489 five year survivors of childhood cancer in Great Britain: population based cohort study publication-title: BMJ – volume: 33 start-page: 3774 year: 2015 end-page: 3780 ident: bib10 article-title: Equivalence ratio for daunorubicin to doxorubicin in relation to late heart failure in survivors of childhood cancer publication-title: J Clin Oncol – volume: 10 start-page: 1100 year: 1982 end-page: 1120 ident: bib15 article-title: Cox's regression model for counting processes: a large sample study publication-title: Ann Stat – volume: 374 start-page: 833 year: 2016 end-page: 842 ident: bib5 article-title: Reduction in late mortality among 5-year survivors of childhood cancer publication-title: N Engl J Med – year: April, 2015 ident: bib1 article-title: SEER Cancer Statistics Review, 1975–2012 – volume: 1 start-page: 37 year: 2011 end-page: 42 ident: bib2 article-title: Latest estimates of survival rates of the 24 most common cancers in adolescent and young adult Americans publication-title: J Adolesc Young Adult Oncol – volume: 26 start-page: 312 year: 2017 end-page: 320 ident: bib27 article-title: Adolescents and young adults with acute lymphoblastic leukemia and acute myeloid leukemia: impact of care at specialized cancer centers on survival outcome publication-title: Cancer Epidemiol Biomarkers Prev – volume: 61 start-page: 53 year: 2014 end-page: 67 ident: bib9 article-title: The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study publication-title: Pediatr Blood Cancer – volume: 84 start-page: 1074 year: 1989 end-page: 1078 ident: bib16 article-title: The robust inference for the cox proportional hazards model publication-title: J Am Stat Assoc – year: 2006 ident: bib3 article-title: Closing the gap: research and care imperatives for adolescents and young adults with cancer. Report of the Adolescent and Young Adult Oncology Progress Review Group – volume: 57 start-page: 242 year: 2007 end-page: 255 ident: bib19 article-title: Young adult oncology: the patients and their survival challenges publication-title: CA Cancer J Clin – volume: 26 start-page: 4401 year: 2008 end-page: 4409 ident: bib28 article-title: Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study publication-title: J Clin Oncol – volume: 26 start-page: 3038 year: 2008 end-page: 3045 ident: bib25 article-title: Osteonecrosis in adult survivors of childhood cancer: a report from the childhood cancer survivor study publication-title: J Clin Oncol – volume: 21 start-page: 1359 year: 2003 end-page: 1365 ident: bib21 article-title: Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study publication-title: J Clin Oncol – volume: 160 start-page: 11 year: 2014 end-page: 17 ident: bib29 article-title: General internists' preferences and knowledge about the care of adult survivors of childhood cancer: a cross-sectional survey publication-title: Ann Intern Med – volume: 32 start-page: 1218 year: 2014 end-page: 1227 ident: bib12 article-title: Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study publication-title: J Clin Oncol – volume: 124 start-page: 136 year: 2018 end-page: 144 ident: bib18 article-title: Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: an adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis publication-title: Cancer – volume: 85 start-page: 3227 year: 2000 end-page: 3232 ident: bib24 article-title: Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study publication-title: J Clin Endocrinol Metab – volume: 2 start-page: 193 year: 2016 end-page: 200 ident: bib7 article-title: Long-term risk of hospitalization for somatic diseases in survivors of adolescent or young adult cancer publication-title: JAMA Oncol – volume: 27 start-page: 2308 year: 2009 end-page: 2318 ident: bib8 article-title: The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research publication-title: J Clin Oncol – volume: 166 start-page: 141 year: 2006 end-page: 157 ident: bib11 article-title: Dose reconstruction for therapeutic and diagnostic radiation exposures: use in epidemiological studies publication-title: Radiat Res – year: 2003 ident: bib14 article-title: National Center for Health Statistics Compressed Mortality File on CDC Wonder Online Database; CMF 1999–2013, Series 20, No 2s, 2014; CMF 1968–1988, Series 20, No. 2A, 2000; CMF 1989–1998, Series 20, No. 2E – volume: 160 start-page: 11 year: 2014 ident: 10.1016/S1470-2045(19)30800-9_bib29 article-title: General internists' preferences and knowledge about the care of adult survivors of childhood cancer: a cross-sectional survey publication-title: Ann Intern Med doi: 10.7326/M13-1941 – volume: 354 year: 2016 ident: 10.1016/S1470-2045(19)30800-9_bib6 article-title: Long term cause specific mortality among 34 489 five year survivors of childhood cancer in Great Britain: population based cohort study publication-title: BMJ – volume: 112 start-page: 1646 year: 2008 ident: 10.1016/S1470-2045(19)30800-9_bib20 article-title: What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies publication-title: Blood doi: 10.1182/blood-2008-01-130237 – volume: 67 start-page: 39 year: 2011 ident: 10.1016/S1470-2045(19)30800-9_bib13 article-title: Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring publication-title: Biometrics doi: 10.1111/j.1541-0420.2010.01420.x – volume: 32 start-page: 1218 year: 2014 ident: 10.1016/S1470-2045(19)30800-9_bib12 article-title: Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study publication-title: J Clin Oncol doi: 10.1200/JCO.2013.51.1055 – volume: 355 start-page: 1572 year: 2006 ident: 10.1016/S1470-2045(19)30800-9_bib4 article-title: Chronic health conditions in adult survivors of childhood cancer publication-title: N Engl J Med doi: 10.1056/NEJMsa060185 – volume: 26 start-page: 312 year: 2017 ident: 10.1016/S1470-2045(19)30800-9_bib27 article-title: Adolescents and young adults with acute lymphoblastic leukemia and acute myeloid leukemia: impact of care at specialized cancer centers on survival outcome publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-16-0722 – volume: 61 start-page: 53 year: 2014 ident: 10.1016/S1470-2045(19)30800-9_bib9 article-title: The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study publication-title: Pediatr Blood Cancer doi: 10.1002/pbc.24679 – volume: 166 start-page: 141 year: 2006 ident: 10.1016/S1470-2045(19)30800-9_bib11 article-title: Dose reconstruction for therapeutic and diagnostic radiation exposures: use in epidemiological studies publication-title: Radiat Res doi: 10.1667/RR3525.1 – volume: 10 start-page: 1100 year: 1982 ident: 10.1016/S1470-2045(19)30800-9_bib15 article-title: Cox's regression model for counting processes: a large sample study publication-title: Ann Stat doi: 10.1214/aos/1176345976 – volume: 2 start-page: 193 year: 2016 ident: 10.1016/S1470-2045(19)30800-9_bib7 article-title: Long-term risk of hospitalization for somatic diseases in survivors of adolescent or young adult cancer publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2015.4393 – volume: 85 start-page: 3227 year: 2000 ident: 10.1016/S1470-2045(19)30800-9_bib24 article-title: Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study publication-title: J Clin Endocrinol Metab – volume: 7 start-page: 210 year: 2014 ident: 10.1016/S1470-2045(19)30800-9_bib31 article-title: An overview of chronic disease models: a systematic literature review publication-title: Glob J Health Sci doi: 10.5539/gjhs.v7n2p210 – volume: 339 year: 2009 ident: 10.1016/S1470-2045(19)30800-9_bib17 article-title: Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort publication-title: BMJ doi: 10.1136/bmj.b4606 – volume: 27 start-page: 2308 year: 2009 ident: 10.1016/S1470-2045(19)30800-9_bib8 article-title: The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research publication-title: J Clin Oncol doi: 10.1200/JCO.2009.22.3339 – volume: 57 start-page: 242 year: 2007 ident: 10.1016/S1470-2045(19)30800-9_bib19 article-title: Young adult oncology: the patients and their survival challenges publication-title: CA Cancer J Clin – volume: 26 start-page: 3038 year: 2008 ident: 10.1016/S1470-2045(19)30800-9_bib25 article-title: Osteonecrosis in adult survivors of childhood cancer: a report from the childhood cancer survivor study publication-title: J Clin Oncol doi: 10.1200/JCO.2007.14.9088 – volume: 21 start-page: 1359 year: 2003 ident: 10.1016/S1470-2045(19)30800-9_bib21 article-title: Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study publication-title: J Clin Oncol doi: 10.1200/JCO.2003.06.131 – year: 2015 ident: 10.1016/S1470-2045(19)30800-9_bib1 – volume: 84 start-page: 1074 year: 1989 ident: 10.1016/S1470-2045(19)30800-9_bib16 article-title: The robust inference for the cox proportional hazards model publication-title: J Am Stat Assoc doi: 10.1080/01621459.1989.10478874 – volume: 91 start-page: 1723 year: 2006 ident: 10.1016/S1470-2045(19)30800-9_bib23 article-title: Acute ovarian failure in the childhood cancer survivor study publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2006-0020 – volume: 26 start-page: 4401 year: 2008 ident: 10.1016/S1470-2045(19)30800-9_bib28 article-title: Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study publication-title: J Clin Oncol doi: 10.1200/JCO.2008.16.9607 – year: 2006 ident: 10.1016/S1470-2045(19)30800-9_bib3 – volume: 124 start-page: 136 year: 2018 ident: 10.1016/S1470-2045(19)30800-9_bib18 article-title: Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: an adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis publication-title: Cancer doi: 10.1002/cncr.30979 – volume: 374 start-page: 833 year: 2016 ident: 10.1016/S1470-2045(19)30800-9_bib5 article-title: Reduction in late mortality among 5-year survivors of childhood cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1510795 – volume: 10 start-page: 249 year: 2014 ident: 10.1016/S1470-2045(19)30800-9_bib26 article-title: A systematic review of selected musculoskeletal late effects in survivors of childhood cancer publication-title: Curr Pediatr Rev doi: 10.2174/1573400510666141114223827 – volume: 1 start-page: 37 year: 2011 ident: 10.1016/S1470-2045(19)30800-9_bib2 article-title: Latest estimates of survival rates of the 24 most common cancers in adolescent and young adult Americans publication-title: J Adolesc Young Adult Oncol doi: 10.1089/jayao.2010.0005 – volume: 33 start-page: 3774 year: 2015 ident: 10.1016/S1470-2045(19)30800-9_bib10 article-title: Equivalence ratio for daunorubicin to doxorubicin in relation to late heart failure in survivors of childhood cancer publication-title: J Clin Oncol doi: 10.1200/JCO.2015.61.5187 – volume: 169 start-page: 1381 year: 2009 ident: 10.1016/S1470-2045(19)30800-9_bib22 article-title: Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study publication-title: Arch Intern Med doi: 10.1001/archinternmed.2009.209 – reference: 32066544 - Lancet Oncol. 2020 Mar;21(3):327-329 |
| SSID | ssj0017105 |
| Score | 2.6768284 |
| Snippet | Treatment outcomes among survivors of cancer diagnosed during adolescence and early young adulthood have not been characterised independently of survivors of... SummaryBackgroundTreatment outcomes among survivors of cancer diagnosed during adolescence and early young adulthood have not been characterised independently... Summary Background Treatment outcomes among survivors of cancer diagnosed during adolescence and early young adulthood have not been characterised... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 421 |
| SubjectTerms | Adolescence Adolescent Adult Bone cancer Cancer Survivors - statistics & numerical data Cancer therapies Childhood Children Chronic Disease Chronic illnesses Cohort analysis Combined Modality Therapy Diagnosis Female Follow-Up Studies Hematology, Oncology, and Palliative Medicine Humans Leukemia Longitudinal Studies Lymphoma Male Mortality Neoplasms - mortality Neoplasms - pathology Neoplasms - therapy Neuroblastoma Prognosis Retrospective Studies Risk assessment Risk Factors Siblings Studies Survival Rate Survivors - statistics & numerical data Teenagers Terminology Time Factors Tumors Young Adult Young adults |
| Title | Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1470204519308009 https://www.clinicalkey.es/playcontent/1-s2.0-S1470204519308009 https://dx.doi.org/10.1016/S1470-2045(19)30800-9 https://www.ncbi.nlm.nih.gov/pubmed/32066543 https://www.proquest.com/docview/2425647238 https://www.proquest.com/docview/2357460972 |
| Volume | 21 |
| WOSCitedRecordID | wos000518470100046&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1474-5488 dateEnd: 20251009 omitProxy: false ssIdentifier: ssj0017105 issn: 1470-2045 databaseCode: BENPR dateStart: 20000901 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Proquest Health and Medical Complete customDbUrl: eissn: 1474-5488 dateEnd: 20251009 omitProxy: false ssIdentifier: ssj0017105 issn: 1470-2045 databaseCode: 7X7 dateStart: 20000901 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Nursing & Allied Health Database customDbUrl: eissn: 1474-5488 dateEnd: 20251009 omitProxy: false ssIdentifier: ssj0017105 issn: 1470-2045 databaseCode: 7RV dateStart: 20000901 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1474-5488 dateEnd: 20251009 omitProxy: false ssIdentifier: ssj0017105 issn: 1470-2045 databaseCode: 8C1 dateStart: 20000901 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZoixAX3oWFshokDnAwTezEXnNBsGrFAVZVC2hvVvwIqlSSkuxW6k_j3-FxHnuhFIlLDkkmjpLP48_2zDeEvHSF8WFc8JSXTNKMSUOVZRjr6mzOUINfmVhsQi4Ws-VSHfULbm0fVjn4xOioXW1xjXwfqTFKnfPZu_OfFKtG4e5qX0Jji-ykLMmwY87mY4hHKrsQxjSTCUXZ9U0Gz_7JePJVql5z5E1UXTU2XcU94xh0ePd_3_4eudOzT3jfweU-ueGrB-TW535__SH59SlQT_gRKXmg51BUDmwnnwtdxiSE-bPrwrzgtIKzuvpO0btDuw5O56JuWqhL8CibTDdqUfFBl-hYIAp-gEWwNe1bKKDxq6YeEj4BC_Y2eH-nlQKY_gKBpMKowQzzaAsnfYOAoZCXj8jXw4Mv84-0L-5AbSBRK6q4NYVQpVI5t2linDQ8t06kRsgkL2xROJlnwiVOikA6sBINL4zwZS4kK0vDd8l2VVf-CQFlShd4aJl7X2aGlSrMukUuAzZzlYX_PCHZ8Fu17ZXPsQDHmR5D3BANGtGgU6UjGrSakDej2Xkn_XGdgRgwo4e81uCJdRicrjOUfzL0be9PWp3qlumks2ZREiiaBsvZaNlTpo4K_UujewNU9djOBqcT8mK8HDwObiMVla_X4R6ey0yg7NOEPO66w_h9OIvlrPnTvz_8GbnNcN0ixvLtke1Vs_bPyU17sTptmynZksff8LiU8Tibxm49JTsfDhZHx78B_K1QZw |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKQZQL78dCgUECiR5MEzuJYySE0ELVqtsVUovUm4kdp6pUkpLsFu2f4s6_w-M89kIplx64JvlsyZmX7ZlvCHmZZ9o6v2ApL5igEROaSsMw1zU3MUMOfql9swkxnaaHh_LzCvnZ18JgWmVvE72hziuDZ-SbGBoj1TlP359-p9g1Cm9X-xYarVjs2sUPt2Vr3u18dP_3FWNbnw7G27TrKkCN894zKrnRWSILKWNuwkDnQvPY5EmoExHEmcmyXMRRkge5SJy3wxYoPNOJLeJEsKLQ3I17hVxFJjvc7KXjIaUkFG3KZBiJgCLN-7JiaHN_ePg6lBsc4zQqz_OF58W63udt3frfVus2udlF1_ChVYc7ZMWWd8n1vS5_4B75NXGhNXzzWw63_YCszMG09MDQVoSCqfASH5URjks4qcojit4LmrkzqmdV3UBVgEVaaLpkw_IDLdBwgic0AYPKVDdvIYPazuqqL2gFbEhc4_ctFwxgeQ-4IBwGjmkYeyzsdxMCpnou7pMvl7JwD8hqWZX2EQGpi9zF2UVsbRFpVkie8iQWTvdiGTm5GpGoFyNlOmZ3bDByooYUPpQ-hdKnQqm89Ck5Im8G2GlLbXIRIOllVPV1u87TKOd8LwKKPwFt09nLRoWqYSpo0cxTHnmoQ6YDsgsJ21DvXyZd71VDDfMs9WJEXgyvnUXFa7KstNXcfcNjESVIazUiD1v1G9aHM9-umz_---DPydr2wd5ETXamu0_IDYZnND5vcZ2szuq5fUqumbPZcVM_8wYEyNfL1sHfjYOpNg |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKQRUX3tCFAoMEEhzMbuwkXiMhhLasqFpWlQpSbyZ2bFSpTUqyW7Q_DX4dHuexF0q59MA1ydiSM9_M2J75hpDneaat9wuWcscEjZnQVBqGua65SRhy8Esdmk2I2Wx8eCj318ivrhYG0yo7mxgMdV4aPCMfYmiMVOd8PHRtWsT-9vTd6XeKHaTwprVrp9GoyK5d_vDbt_rtzrb_1y8Ym374PPlI2w4D1HhPPqeSG52l0kmZcBONdC40T0yeRjoVoyQzWZaLJE7zUS5S7_mwHQrPdGpdkgrmnOZ-3CvkquBei7FKfdKnl0SiSZ-MYjGiSPm-qh4aHvQPX0byFceYjcrz_OJ5cW_wf9Ob__PK3SI32qgb3jcwuU3WbHGHbHxq8wrukp97PuSGk7AV8dsSyIocTEMbDE2lKJgSL_cRpHBUwHFZfKPo1aBeeGN7VlY1lA4s0kXTFUtWGGiJBhUC0QkYBFlVv4EMKjuvyq7QFbBRcYXfNxwxgGU_4INz6LmnYRJk4aCdEDAFdHmPfLmUhbtP1ouysJsEpHa5j79dYq2LNXOSj3maCI_JRMZexwYk7lRKmZbxHRuPHKs-tQ81UaEmqkiqoIlKDsjrXuy0oTy5SCDt9FV19bzeAynvlC8SFH8StHVrR2sVqZqpUSPNAhVSEPWS416yDRWbEPBfJt3qYKL6eVYYGZBn_WtvafH6LCtsufDf8ETEKdJdDciDBor9-nAW2njzh38f_CnZ8NBTezuz3UfkOsOjm5DOuEXW59XCPibXzNn8qK6eBFsC5OtlQ_A31pCx-w |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Late+mortality+and+chronic+health+conditions+in+long-term+survivors+of+early-adolescent+and+young+adult+cancers%3A+a+retrospective+cohort+analysis+from+the+Childhood+Cancer+Survivor+Study&rft.jtitle=The+lancet+oncology&rft.au=Suh%2C+Eugene&rft.au=Stratton%2C+Kayla+L&rft.au=Leisenring%2C+Wendy+M&rft.au=Nathan%2C+Paul+C&rft.date=2020-03-01&rft.pub=Elsevier+Ltd&rft.issn=1470-2045&rft.eissn=1474-5488&rft.volume=21&rft.issue=3&rft.spage=421&rft.epage=435&rft_id=info:doi/10.1016%2FS1470-2045%2819%2930800-9&rft.externalDocID=S1470204519308009 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1470-2045&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1470-2045&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1470-2045&client=summon |